Skip to main content

Management of Helicobacter pylori–Related Diseases, An Issue of Gastroenterology Clinics of North America

  • 1st Edition, Volume 44-3 - September 3, 2015
  • Author: Akiko Shiotani
  • Language: English
  • Hardback ISBN:
    9 7 8 - 0 - 3 2 3 - 3 9 5 6 5 - 6
  • eBook ISBN:
    9 7 8 - 0 - 3 2 3 - 3 9 5 6 6 - 3

Helicobacter pylori (H. pylori) infection is a worldwide disease with a significant morbidity and mortality; it is the leading cause of non-ulcer dyspepsia, peptic ulcers and… Read more

Management of Helicobacter pylori–Related Diseases, An Issue of Gastroenterology Clinics of North America

Purchase options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Institutional subscription on ScienceDirect

Request a sales quote
Helicobacter pylori (H. pylori) infection is a worldwide disease with a significant morbidity and mortality; it is the leading cause of non-ulcer dyspepsia, peptic ulcers and gastric tumors, including low-grade mucosa-associated lymphoid tissue-lymphoma and adenocarcinoma. In addition, it has also been recognized that the interaction between H. pylori and non-steroidal, anti-inflammatory drugs is damaging to the gastroduodenal mucosa. H. pylori treatment still remains a challenge for physicians, since no current first-line therapy is able to cure the infection in all treated patients. This issue will serve to update gastroenterologists on current therapies, evaluation and management of disease progression, and the future of management of H. pylori infection.